Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 845 (LINC00845) is a non-coding RNA gene producing RNA transcripts longer than 200 nucleotides that do not overlap with protein-coding genes. As a member of the lincRNA family, it does not encode a protein but may contribute to chromatin remodeling, transcriptional regulation, and the fine-tuning of gene expression, and is likely to exhibit tissue specificity. While some lincRNAs are emerging as modulators in cancer and other diseases, there is currently no evidence linking LINC00845 specifically to disease or therapeutic intervention[1][3][5][9].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 845 (LINC00845).